Prognostic Value of Learning and Retention Measures from the Free and Cued Selective Reminding Test to Identify Incident Mild Cognitive Impairment
- PMID: 33745492
- PMCID: PMC8455713
- DOI: 10.1017/S1355617721000291
Prognostic Value of Learning and Retention Measures from the Free and Cued Selective Reminding Test to Identify Incident Mild Cognitive Impairment
Abstract
Objective: To compare the predictive validity of learning and retention measures from the picture version of the Free and Cued Selective Reminding Test with Immediate Recall (pFCSRT + IR) for identifying incident mild cognitive impairment (MCI).
Methods: Learning was defined by the sum of free recall (FR) and retention by delayed free recall (DFR) tested 15-20 min later. Totally, 1422 Baltimore Longitudinal Study of Aging (BLSA) participants (mean age 69.6 years, 54% male, mean 16.7 years of education) without dementia or MCI received the pFCSRT + IR at baseline and were followed longitudinally. Cox proportional hazards models were used to evaluate the effect of baseline learning and retention on risk of MCI.
Results: In total, 187 participants developed MCI over a median of 8.1 years of follow-up. FR and DFR each predicted incident MCI adjusting for age, sex, and education. Also, each independently predicted incident MCI in the presence of the other with similar effect sizes: around 20% decrease in the hazard of MCI corresponding to one standard deviation increase in FR or DFR.
Conclusion: The practice of preferring retention over learning to predict incident MCI should be reconsidered. The decision to include retention should be guided by time constraints and patient burden.
Keywords: Alzheimer’s disease; Free and Cued Selective Reminding Test; Memory disorders; Mild cognitive impairment; Preclinical dementia; Prospective studies; Retention; Verbal learning.
Figures
Similar articles
-
Timing of onset and rate of decline in learning and retention in the pre-dementia phase of Alzheimer's disease.J Int Neuropsychol Soc. 2019 Aug;25(7):699-705. doi: 10.1017/S1355617719000304. J Int Neuropsychol Soc. 2019. PMID: 31094304 Free PMC article.
-
Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.J Alzheimers Dis. 2017;58(3):909-918. doi: 10.3233/JAD-170073. J Alzheimers Dis. 2017. PMID: 28527215
-
Diagnostic and Prognostic Accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in Preclinical Alzheimer's Disease and Incident Mild Cognitive Impairment: Implications for Defining Subtle Objective Cognitive Impairment.J Alzheimers Dis. 2020;76(1):261-274. doi: 10.3233/JAD-200087. J Alzheimers Dis. 2020. PMID: 32538841 Free PMC article.
-
The free and cued selective reminding test: Validation for mild cognitive impairment and Alzheimer's disease.J Neuropsychol. 2015 Sep;9(2):242-57. doi: 10.1111/jnp.12048. Epub 2014 Jun 3. J Neuropsychol. 2015. PMID: 24894485
-
Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.Geriatr Gerontol Int. 2017 Oct;17(10):1603-1609. doi: 10.1111/ggi.12940. Epub 2016 Dec 1. Geriatr Gerontol Int. 2017. PMID: 27910252
Cited by
-
Recruitment of a multi-site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial.Alzheimers Dement. 2021 Nov;17(11):1808-1817. doi: 10.1002/alz.12401. Epub 2021 Jul 23. Alzheimers Dement. 2021. PMID: 34297895 Free PMC article. Clinical Trial.
-
Free Recall Outperforms Story Recall in Associations with Plasma Biomarkers in Preclinical Alzheimer Disease.J Prev Alzheimers Dis. 2024;11(6):1696-1702. doi: 10.14283/jpad.2024.130. J Prev Alzheimers Dis. 2024. PMID: 39559880 Free PMC article.
-
Exploring the Association between Amyloid-β and Memory Markers for Alzheimer's Disease in Cognitively Unimpaired Older Adults.J Prev Alzheimers Dis. 2024;11(2):339-347. doi: 10.14283/jpad.2024.11. J Prev Alzheimers Dis. 2024. PMID: 38374740 Free PMC article.
-
Association of Stages of Objective Memory Impairment With Incident Symptomatic Cognitive Impairment in Cognitively Normal Individuals.Neurology. 2023 May 30;100(22):e2279-e2289. doi: 10.1212/WNL.0000000000207276. Epub 2023 Apr 19. Neurology. 2023. PMID: 37076305 Free PMC article.
-
The memory binding test in a longitudinal study of cognitive aging and preclinical disease.Neuropsychology. 2024 Sep;38(6):570-588. doi: 10.1037/neu0000952. Epub 2024 Jul 8. Neuropsychology. 2024. PMID: 38976381
References
-
- Albert M, Moss M, Tanzi R, & Jones K (2001). Preclinical prediction of AD using neuropsychological tests. Journal of the International Neuropsychological Society 7, 631–639. - PubMed
-
- American Psychiatric Association. (1987). Diagnostic and Statistical Manual of Mental Disorders (3rd ed.). Washington, D.C.: American Psychiatric Association Press.
-
- Auriacombe SM, Helmer CMDP, Amieva HP, Berr CP, Dubois BM, Dartigues JFMDP (2010) Validity of the Free and Cued Selective Reminding Test in predicting dementia: The 3C Study. Neurology 74, 1760–1767. - PubMed
-
- Becker JT, Boller F, Saxton J, & McGonigle-Gibson KL (1987). Normal rates of forgetting of verbal and non-verbal material in Alzheimer’s disease. Cortex, 23(1), 59–72. - PubMed
Publication types
MeSH terms
Grants and funding
- K23 AG049466/AG/NIA NIH HHS/United States
- R01 AG048642/AG/NIA NIH HHS/United States
- K23 NS107643/NS/NINDS NIH HHS/United States
- U10 NS077308/NS/NINDS NIH HHS/United States
- RF1 AG054548/AG/NIA NIH HHS/United States
- R01 AG057531/AG/NIA NIH HHS/United States
- R01 AG057548/AG/NIA NIH HHS/United States
- P01 AG003949/AG/NIA NIH HHS/United States
- R01 AG060933/AG/NIA NIH HHS/United States
- R56 AG057548/AG/NIA NIH HHS/United States
- RF1 AG057531/AG/NIA NIH HHS/United States
- P30 AG066507/AG/NIA NIH HHS/United States
- R21 AG056920/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical